Voyageur Pharmaceuticals Cash Flow Statement

Financials in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Net Income	-3.53	-1.71	-1.4	-1.75	-2.05
Depreciation & Amortization	0	0	0	0.01	0.01
Stock-Based Compensation	0.81	0.42	0.23	0.15	0.74
Other Adjustments	0	0.01	0.06	0.12	-
Change in Receivables	-0.08	-0.02	-0.01	0.02	-
Changes in Inventories	0.02	-0.06	-	-0	0
Changes in Accounts Payable	-0.13	1.08	0.07	-0.19	-0.08
Changes in Other Operating Activities	0.02	-0.03	0.05	-0.07	-0.26
Operating Cash Flow	-2.89	-0.3	-0.99	-1.72	-1.65
Capital Expenditures	-	-	-	-0	-0.02
Sale of Property, Plant & Equipment	-	-	-	0.01	-
Other Investing Activities	-0.27	-0.17	-0.17	-0.28	-0.42
Investing Cash Flow	-0.27	-0.17	-0.17	-0.27	-0.44
Long-Term Debt Issued	-	-	-	-	-0
Long-Term Debt Repaid	-	-	-	-0.02	-0.01
Net Long-Term Debt Issued (Repaid)	-	-	-	-0.02	-0.02
Issuance of Common Stock	3.35	0.66	1.2	1.29	3.09
Net Common Stock Issued (Repurchased)	3.35	0.66	1.2	1.29	3.09
Other Financing Activities	-0.08	-0.03	-0.06	-0.06	-0.18
Financing Cash Flow	3.26	0.63	1.14	1.21	2.9
Net Cash Flow	0.1	0.16	-0.03	-0.78	0.81
Free Cash Flow	-2.89	-0.3	-0.99	-1.72	-1.67
FCF Margin	-24756.48%	-	-	-	-
Free Cash Flow Per Share	-0.02	-0.00	-0.01	-0.02	-0.02
Levered Free Cash Flow	-3.62	-0.71	-1.28	-2.03	-2.43
Unlevered Free Cash Flow	-3.62	-0.71	-1.28	-2.01	-2.41

Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.